Clinical Trial Update: Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating paclitaxel plus cisplatin as first-line chemotherapy for high-risk gestational trophoblastic tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Trophoblastic Neoplasms

Drugs mentioned

• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Weiguo Lv | Conditions: Gestational Trophoblastic Neoplasms | Phase 3 | Status: UNKNOWN